Genor Biopharma Funding: $160M Raised, Series B (2020)

Genor Biopharma is based in Shanghai, China. It has raised $160M in total funding. Latest round: Series B.

Genor Biopharma funding overview

Genor Biopharma is based in Shanghai, China. Genor Biopharma has raised $160M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2020. The round record for Genor Biopharma runs through 2020; nothing later has been disclosed. Investors on record include Hillhouse Capital, Temasek Holdings, Haitong Capital, Cavenham PE, CR-CP Life Science Fund. 5 distinct backers are named across the disclosed rounds.

Genor Biopharma at a glance

Total raised
$160M
Latest round
Series B
Latest round date
June 2020
Headquarters
Shanghai, China
Notable investors
Hillhouse Capital, Temasek Holdings, Haitong Capital, Cavenham PE, CR-CP Life Science Fund

Frequently asked about Genor Biopharma funding

How much has Genor Biopharma raised?
Genor Biopharma has raised $160M in total disclosed funding across the rounds on record.
Who has invested in Genor Biopharma?
Hillhouse Capital, Temasek Holdings, Haitong Capital, Cavenham PE, CR-CP Life Science Fund are named among the investors backing Genor Biopharma.
What was the latest Genor Biopharma funding round?
The most recent disclosed round is a Series B, announced in June 2020.
Where is Genor Biopharma based?
Genor Biopharma is based in Shanghai, China.
When did Genor Biopharma last raise?
The last disclosed Genor Biopharma round closed in June 2020 at Series B.

Every Genor Biopharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Shanghai at a similar stage.

Companies related to Genor Biopharma (35)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026